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Abstract
Base excision repair (BER) is the major pathway for the repair of oxidized bases 
and apurinic/apyrimidinic (abasic; AP) sites produced by reaction with reactive 
oxygen/nitrogen species (ROS/RNS). These metabolites are generated spontane-
ously by endogenous cellular processes and also by environmental agents. Because 
most of these lesions are promutagenic, linked to diverse disease-associated somatic 
mutations, as well as heritable single nucleotide polymorphisms (SNPs) in the 
normal human population, their prompt repair is warranted. Impairment of repair 
leading to mutation, a hallmark of cancer, underscores the essentiality of BER 
for maintaining genome integrity in humans and other mammals. In mammals, 
repair of oxidized bases and other BER substrates is initiated by DNA glycosylases 
(DGs), which excise the damaged bases and cleave the DNA strands at the resulting 
AP sites, followed by sequential end processing, gap-filling DNA synthesis, and 
ligation. In vitro BER performed with naked DNA substrates has been extensively 
studied, which delineates its basic mechanistic steps and subpathways. However, 
recent interest is directed to unraveling BER in cell chromatin, including its regula-
tion via posttranslational modifications (PTMs), which occurs possibly in concert 
with nucleosome remodeling. Emerging reports on various PTMs of BER enzymes 
indicate that the PTMs, while dispensable for the enzymatic activity, regulate 
overall repair by modulating interactions with other repair proteins and chromatin 
factors, assembly of BER complexes, as well as turnover of the proteins, and may 
ultimately dictate the cellular phenotype. Here, we discuss recent advances in the 
BER field by reviewing the PTMs and how they regulate BER in chromatin.
Keywords: oxidative stress, base oxidation, base excision repair,  
posttranslational modifications, acetylation, phosphorylation, SUMOylation, 
methylation, chromatin
1. Introduction
DNA, the genetic repository of all cellular functions, is packaged with histones 
into chromatin consisting of nucleosome units. One hundred forty-seven base pair 
(bp) segments in DNA wrap ~1.65 times in a left-handed superhelical turn around a 
histone octamer consisting of two histone H2A-H2B dimers and a H3-H4 tetramer, 
which form the nucleosome core; the adjacent nucleosomes are separated by some 
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50 bp unfolded, linker DNA bound to histone H1 or H5. Organization of DNA 
into chromatin enables the compaction required to accommodate large eukaryotic 
genomes inside the cell nucleus. This compaction renders DNA inaccessible to any 
DNA transaction machinery. Replication and transcription are tightly coordinated 
with specific interactions of their complexes with DNA [1, 2].
The integrity of DNA is under constant threat, naturally from endogenous 
sources, as well as by environmental factors in the form of a chemical addition, an 
alteration in the nitrogen base structure, thereby creating an abnormal nucleotide, 
or a break in one or both strands of DNA [3–8]. Cellular metabolic processes includ-
ing mitochondrial respiration and hydrolytic reactions generate reactive molecules, 
such as reactive oxygen species (ROS), reactive nitrogen species (RNS), and alkylat-
ing agents. Some chemical bonds in DNA are susceptible to spontaneous hydrolysis. 
About 70,000 lesions are generated per cell, per day in humans. Single-strand 
breaks (SSBs), as well as a plethora of oxidized bases, are formed during oxida-
tive genome damage. In addition, deamination, depurination, depyrimidination, 
double-strand breaks (DSBs), propano-, etheno-, and malondialdehyde-derived 
DNA adducts, base propenals, and alkylated bases are also formed endogenously. 
Environmental factors such as UV rays, ionizing radiation (IR), heat, and chemicals 
from tobacco smoke and industrial sources pose additional risks to DNA.
2. Oxidative genome damage and oxidized bases
For aerobic organisms, oxygen acts like a double-edged sword; while it is 
absolutely essential for life, it is also a threat to the life, recognized as the “Oxygen 
Paradox” [9–11]. ROS, which include the superoxide anion (O2
•−), hydrogen perox-
ide (H2O2), singlet oxygen (
1O2), and the hydroxyl radical (
•OH), along with RNS, 
for example, peroxynitrite (ONOO−) react with all biological molecules including 
DNA. The hydroxyl radical having the highest reduction potential is mainly gener-
ated from Fenton reaction between reduced redox active metal ions (Fe2+, Cu+) and 
H2O2 [12], as well as by the IR-induced radiolysis of water [13]. A wide variety of 
cellular antioxidant defense mechanisms including both redox-buffering enzymatic 
and nonenzymatic systems have evolved, for example, superoxide dismutases, cata-
lases, glutathione peroxidases, peroxiredoxins, and glutaredoxins; these counteract 
the detrimental effect of oxidative stress to the biological molecules, and an imbal-
ance in their homeostasis leads to increased damage to the biomolecules [14].
A plethora of oxidized base lesions are generated mostly from guanine (G) in 
DNA, which has the lowest redox potential among the natural bases. Other lesions 
including 2-deoxyribose modifications, SSBs, DSBs, and protein-DNA cross-links are 
also ROS reaction products in DNA [10, 14–17]. Nearly 100 such lesions have been 
identified; however, because of the lack of sensitivity of the techniques used to iden-
tify the lesions and inherent instability of some of them, the total number formed in 
the genome under a pro-oxidant environment is likely to be much higher [18].
The most commonly formed oxidized base lesion is 7,8-dihydro-8-oxoguanine 
(8-oxoguanine, 8-oxoG), which was discovered by Kasai and Nishimura in 1983 
and coined as 8-hydroxyguanine [19–21]. All the nucleobases are also ionized by IR 
and by high intensity 266-ns laser photolysis. The DNA bases undergo one-electron 
oxidation (one electron ionization potential of G<A<C~T). 8-oxoG is generated at 
a much higher level (>5-fold) than the combined level of other one-electron base 
oxidation products. Singlet oxygen (1O2), the major ROS in UVA-mediated oxida-
tion of DNA, specifically targets G and 2-deoxyribose moiety [22–24]. Other major 
oxidized base lesions are 5-hydroxy-6-hydrothymine, thymine glycol (TG), cyto-
sine glycol (CG), 5-hydroxycytosine (5-OHC), uracil glycol (UG), 5-hydroxyuracil 
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(5-OHU), 8-hydroxyadenine, and 2-hydroxyadenine [14, 17]. Hypochlorous acid 
(HOCl), generated by myeloperoxidase in neutrophils during inflammation, chlo-
rinates both DNA and RNA bases [25, 26], and the main products are 5-chlorocy-
tosine, 8-chloroadenine, and 8-chloroguanine. A summary of commonly formed 
oxidized bases detected in cellular DNA is shown in Table 1 [16]. Apart from 
ROS-induced generation of oxidized bases, 5-hydroxymethylcytosine (5hmC), 
5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) are formed enzymati-
cally during transcriptional reprogramming involving oxidative demethylation 
of 5-methyl C (5mC), mostly localized in promoter CpG islands, induced by TET 
dioxygenases [27, 28]. However, enzymatically generated 5-methyl C oxidation 
products are produced >2-fold higher than that from direct oxidative damage to 
DNA [29, 30]. Additionally, tandem base lesions are produced by radicals gener-
ated from •OH or one-electron oxidation reactions. Examples include the addition 
of either 5-(uracilyl)methyl radicals or 6-hydroxy-5,6-dihydrocytosin-5-yl radicals 
to 5′-adjacent guanine moieties in the DNA of cells exposed to H2O2 [31, 32] and 
formation of a guanine-thymine cross-link upon initial formation of guanine radi-
cal cation [33, 34]. One-electron oxidation also leads to DNA-protein cross-links. 
UVA irradiation of 6-thioguanine-containing DNA forms DNA-protein cross-links 
in human cells [33, 35].
3. Fate of oxidized bases and accumulation of mutations
ROS-induced oxidized base lesions and AP sites if left unrepaired are replicated 
by replicative or DNA translesion synthesis (TLS) polymerases [36]. Their mis-
replication generates mutations, a hallmark of cancer genomes, which account for 
two-thirds of single base pair substitutions [37–40]. Furthermore, single nucleotide 
polymorphisms (SNPs), observed in normal human genomes, also likely result 
from such spontaneous single base pair substitutions. U and 5-OHU, the spontane-
ous and ROS-induced oxidative deamination product of C, respectively, preferably 
pair with A during replication, resulting in GC → AT transition mutation; 8-oxoG, 
Table 1. 
Common oxidized bases detected in DNA.
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the predominant oxidized base lesion mispairs with A, leading to GC → TA trans-
version mutation [41, 42]. In response to continuous assault by both endogenous 
and environmental factors, cellular defense mechanisms including diverse DNA 
repair pathways have evolved in all organisms to correct these base modifications 
and maintain genomic integrity.
4. Base excision repair of oxidized bases
Base excision repair (BER) is responsible for repairing most oxidized base 
lesions, AP sites, and DNA SSBs. The basic mechanism of BER first elucidated in 
Escherichia coli is broadly conserved across all organisms, as highlighted in several 
reviews [43–46]. BER requiring only four or five enzymes in the basic reaction steps 
is initiated with excision of the damaged base by a monofunctional DNA glycosyl-
ase (DG), for example, uracil-DNA glycosylase (UDG) or 3-methyladenine-DNA 
glycosylase, generating an abasic apurinic/apyrimidinic (AP) site due to hydrolysis 
of the N-glycosidic bond of the damaged base. The AP endonuclease (APE1 in 
mammalian cells) cleaves the resulting AP site in the second step and generates 3′ 
OH and 5′ deoxyribose phosphate (dRP) termini. The DNA polymerase in the third 
step fills in the single nucleotide gap. In mammalian cells, DNA polymerase β (Pol β) 
also has intrinsic dRP lyase activity, which cleaves the dRP residue and generates 
5′ phosphate; the resulting nick after incorporation of the correct base is sealed by 
DNA ligase III (Lig III) complexed with XRCC1 in the final step.
The BER initiating DGs for oxidized bases, on the other hand, are bifunctional 
with intrinsic AP lyase activity. The bifunctional oxidized base-specific DGs further 
process the AP site via β or βδ lyase reaction. The Nth family of DGs, OGG1, and 
NTH1, via β eliminations generates 3′ phospho α,β-unsaturated aldehyde (3′ PUA; 
formally named 3′ phospho 4-hydroxylpentenal) and 5′ phosphate at the strand 
break. NTH1 prefers oxidized pyrimidines as substrates, and 8-oxoG and ring opened 
guanine, that is, formamidopyrimidine (Fapy-G), are preferred substrates for OGG1. 
The Fpg/Nei family DGs NEIL1, NEIL2, NEIL3, discovered by us and others [47–51] 
catalyze βδ elimination and remove the deoxyribose residue to produce a 3′ phosphate 
and 5′ phosphate at the strand break. NEILs prefer modified pyrimidine substrates, 
NEIL1 having preference for ring-opened purines, for example, Fapy-A and 
Fapy-G. The activity and substrate specificity of NEILs depend on the DNA structure, 
and NEILs have significant 5-OHU excision activity with single-stranded or bubble, 
forked DNA. In contrast, OGG1 and NTH1 prefer double-stranded DNA substrates. 
Usually, the base excision and lyase reactions act in a concerted sequence. However, 
due to weak lyase activity of OGG1, intact AP sites are the major product after OGG1-
catalyzed cleavage of 8-oxoG [52, 53]. All these bifunctional DGs have broad and 
overlapping substrate range and possess backup activity for many base lesions. This 
accounts for the fact that only few DGs have been discovered so far for much larger 
number of oxidized bases and for the nonessentiality of individual DGs.
The 3′ phosphate generated by the NEILs by βδ elimination is a poor substrate 
for mammalian APE1 and is processed by polynucleotide kinase phosphatase 
(PNKP) [54–57]. Thus, for oxidized bases, the DGs actually define the subsequent 
steps. APE1 is responsible for processing the β elimination product of OGG1 and 
NTH1, whereas PNKP is required for generating 3′-OH termini from 3′ phosphate, 
a βδ elimination product of NEILs. Furthermore, AP sites and 3′ PUA generated by 
other DNA glycosylases can also be processed through a NEIL-PNKP-dependent 
pathway [53, 57]. This alternative repair route provides the functional redundancy 
in mammalian BER for genome safeguarding against a plethora of endogenous and 
induced oxidative damages.
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BER, in the simplistic model, generates a 1-nucleotide gap after excision 
of the damaged base and has been termed single nucleotide BER (SN-BER) or 
short-patch BER (SP-BER). In contrast, long-patch BER (LP-BER) involves repair 
synthesis of two to eight deoxynucleotides. The 5′ blocking group after oxida-
tion of AP sites cannot be removed by Pol β via its dRP lyase activity. Instead it 
is removed by 5′-flap endonuclease 1 (FEN-1), which is normally required for 
removing the 5′ RNA primers from Okazaki fragments during DNA replication. 
Thus, the subsequent steps of LP-BER are identical to that of DNA replication, uti-
lizing DNA replication machinery, involving DNA polymerases δ/ε (Pol δ/ε) and 
DNA ligase I (Lig I). These enzymes including FEN-1 are recruited by the sliding 
clamp PCNA, loaded by replication factor-C (RFC), as in replication [58]. Thus, 
the choice of LP-BER vs. SN-BER depends on the 5′-terminus at the base cleavage 
site. With unaltered aldehyde group in deoxyribose, Pol β could carry out SN-BER 
by excising the 5′-dRP. LP-BER becomes necessary for repairing the oxidized AP 
sites, which cannot be processed by the 5′ end cleaning lyase activity of Pol β. The 
nuclear replicative Pol δ/ε lack dRP lyase activity and thus repair synthesis by 
these enzymes have to follow the LP-BER subpathway. Because Pol β-depleted cells 
are resistant to oxidative stress, Pol δ/ε can substitute for DNA Pol β and carry out 
the preferred LP-BER. The BER subpathways are schematically shown in Figure 1, 
adapted from [44].
Figure 1. 
A schematic representation of oxidized base-specific BER subpathways. The damaged base is represented as . 
BER is initiated by the DGs: OGG1, NTH1, NEILs, and converge to common steps for end cleaning, followed by 
repair synthesis and ligation. See text for details.
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5. Prereplicative BER of oxidized bases
The genomic integrity is particularly vulnerable during replication. Transient 
single-stranded (ss) DNA serving as a template during DNA replication after 
unwinding of the duplex genome is particularly vulnerable to ROS, which induces 
oxidized bases, sugar fragments, as well as strand breaks. Most oxidized bases do 
not stall replicative DNA polymerases, but they mispair during replication, thereby 
causing mutations. In contrast, bulky lesions, which stall replicative polymerases, 
block replisomes so as to allow repair. However, blocked replication may also lead 
to fork collapse, causing significant alteration in genomic stability. Furthermore, 
oxidized deoxynucleotides may be incorporated into the progeny strand during 
replication. If left unrepaired, these mutations could accumulate in progeny cells, 
a recipe for pathologies linked to genomic instability, including cancer, accelerated 
aging, and degenerative brain diseases [59, 60]. Repair of oxidative lesions, which 
are generated at much higher abundance than the bulky adducts in the replicat-
ing genome, is thus critical to maintain genomic fidelity. Mammalian cells have 
developed multiple ways to faithfully repair such base damages via prereplicative 
repair in the template strand and postreplicative repair in the progeny strand, 
immediately after replicative synthesis. Both the pathways involve an intricate 
collaboration of specific repair machinery with the replication proteins, likely via 
formation of dynamic “preformed” “repair-replication complexes” at the replica-
tion fork [61, 62].
Repair of most mutagenic base lesions except 8-oxoG, for example, 5-OHU, TG, 
5-OHC, Fapy-A, 8-oxoA, and UG must be carried out prior to replication in order to 
prevent mutation fixation. How such lesions, which do not block replicative Pol δ, 
are flagged for prereplicative repair without causing DSBs was unclear. Our recent 
study showed that the mammalian DG NEIL1 binds to the oxidized lesion sites in ss 
DNA substrates in vitro to facilitate fork regression and participates in prereplicative 
repair of the damaged base in the reannealed duplex DNA [61, 62]. We compared 
the function of NEIL1 in stalling the replication fork at the damage sites for the 
prereplicative repair to the function of a “cow catcher” attached to the front of early 
steam locomotives that served to push aside animals or debris from the track ahead 
of the train’s traversal, in a simplistic analogy to this exquisitely orchestrated pro-
cess [63]. The key features of this “cow catcher” model are the ability of NEIL1 to 
recognize base lesions in ss DNA templates and its nonproductive binding to lesions 
in ss DNA, which, while preventing lethal DSB formation, causes the stalling of the 
replication fork. Subsequent fork reversal allows base lesion repair in the reannealed 
duplex. High expression and activation of NEIL1 in replicating cells, together with 
its stable physical and functional association with proteins in the DNA replica-
tion complex [48, 64–66], are consistent with this surveillance role of NEIL1. The 
human genome during each cell division may be at higher risk for oxidative damage 
whose repair would prevent accumulation of mutations in the daughter cells. Thus 
NEIL1’s prereplicative BER function appears to be critical for preventing mutations 
and maintaining genome fidelity during cell division.
6. Posttranslational modifications of BER proteins
In vitro BER studies, carried out during the last couple of decades, are straightfor-
ward, mainly documenting functions of the repair proteins; however, in the complex 
cellular environment, the pathways are tightly regulated by interactions among the 
partner proteins in multiprotein complexes, which in turn also dictates the stabil-
ity of the complexes. The stability and subcellular localization of these proteins are 
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regulated by site-specific posttranslational modifications (PTMs), primarily involv-
ing acetylation, methylation, phosphorylation, SUMOylation, ubiquitination, and 
PARylation. Thus PTMs are at the root of major regulatory processes, by bestowing 
novel biochemical properties to the modified proteins, including changes in enzy-
matic activity, subcellular localization, interaction partners, protein stability, and 
DNA binding. Although purified recombinant BER proteins without any PTMs are 
proficient in their enzymatic activities, in cellulo BER is significantly affected by these 
PTMs. In this section, we discuss all the major PTMs of BER proteins identified so far.
The hallmark of mammalian DGs and early BER proteins is the presence of 
nonconserved, intrinsically disordered appendages at the N or C terminus, which 
are absent in their bacterial orthologs. Some examples are the N-terminal extension 
in human NTH1 absent in the E. coli Nth, C-terminal extension in human NEIL1 
which is lacking in E. coli Nei, N-terminal extension in human APE1 lacking in E. 
coli Xth [44, 65, 67, 68]. Although the unfolded sequence generally exists at the N or 
C terminus, this could also exist internally as in Human NEIL2, where it may serve 
as a linker of the two domains. Analogous to the situation of histones H3 and H4, 
where mostly all PTMs occur in the disordered N-terminal tail [69, 70], PTMs in 
many early BER proteins are clustered in their disordered domains. See Table 2 for 
the major BER PTMs known so far.
6.1 Acetylation
Acetylation of histones was discovered back in 1963 after the Nobel prize-
winning discovery of acetyl CoA [71–74], and acetylation of histones at the ε-amino 
group of Lys residues in their disordered N-terminal region was shown to suppress 
their abilities to inhibit transcription [75]. Following these pioneering discoveries 
that linked histone acetylation to chromatin decondensation and transcriptional 
activation [76–78], diverse acetylation modifiers were identified and character-
ized. These include various histone acetyltransferases (HATs) such as E1a-binding 
protein p300 (p300), CREB-binding protein (CBP), ortholog of yeast transcription 
regulator Gcn5, TAF(II)250 subunit of transcription factor IID, several members 
of the MYST family (MOZ, YBF2/SAS3, SAS2, and TIP60) and p300/CBP associ-
ated factor (PCAF). Histone deacetylases (HDACs) were subsequently discovered 
as “erasers,” which include distinct members, HDACs1–11 and SIRTs in different 
transcriptional repressor complexes SIN3, NURD, etc., which regulate acetylation/
deacetylation cycle in cells [79–81]. These discoveries set the stage for epigenetic 
regulation of gene expression. Simultaneously, the concept of “reader” proteins 
[80, 82] that specifically recognize acetylated Lys residues through their bromodo-
mains was introduced in addition to the “writers” (HATs) and “erasers” (HDACs). 
Although the first discovered nonhistone protein acetylation dated back in 1997 for 
the tumor suppressor TP53 [83], the overwhelming numbers of nonhistone protein 
acetylation, particularly in large macromolecular complexes involved in chromatin 
remodeling, DNA repair, cell cycle, etc., were appreciated much later, after 2006, 
from mass spectrometric-based proteomic approaches, and provided the global 
scenario of “cellular acetylome” [81, 84–86].
6.2 Phosphorylation
Although enzymatic phosphorylation of proteins was discovered in 1954 
[87], phosphorylated protein was known much earlier, based on identification of 
phosphate in vitellin [88], followed by detection of phosphoserine in this protein 
[89]. During the 1950s, ATP was discovered to be required for phosphorylation 
when the phosphate group was found to be covalently attached to specific serine/
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Functional 
class
BER protein PTM and 
identified site
BER 
activity
Protein 
stability
Reference
DNA 
glycosylases
Uracil DNA 
glycosylase 
(UNG)
Phosphorylation; 
T6, S23, T60, S64, 
T126
+ − [127, 128, 
213]
SUMOylation + [214]
Ubiquitination − [127, 215, 
216]
Single-strand-
selective 
monofunctional 
uracil DNA 
glycosylase 1 
(SMUG1)
Ubiquitination − [215, 216]
Methyl CpG-
binding domain 
protein 4, DNA 
glycosylase 
(MBD4)
Phosphorylation; 
S156,S262
+ [217]
Thymine DNA 
glycosylase 
(TDG)
Acetylation; K94, 
K95, K98
− [129, 130]
Phosphorylation; 
S93, S96, S99
+ [129, 130]
SUMOylation;
K330
K341
−
+
[131, 
218–221]
Ubiquitination − [222, 223]
MutY DNA 
glycosylase 
homolog (MYH)
Phosphorylation; 
S524
+ [224, 225]
Ubiquitination;
C-terminal K 
between aa 475–535
− [226]
8-Oxo guanine 
DNA glycosylase 
1 (OGG1)
Acetylation; K338, 
K341
+ [203]
Phosphorylation; 
S326
+ [227, 228]
Ubiquitination − − [229]
Nei-like DNA 
glycosylase 1 
(NEIL1)
Acetylation; K296, 
K297, K298
+ + [161]
Phosphorylation; 
S61, S207, Y263, 
S269, S306
[230–232]
Nei-like DNA 
glycosylase 2 
NEIL2
Acetylation; K49, 
K153
− [233]
N-methylpurine 
DNA glycosylase 
(MPG)
Acetylation + [234]
Phosphorylation; 
S172
+ [235]
9Regulation of Oxidized Base Repair in Human Chromatin by Posttranslational Modification
DOI: http://dx.doi.org/10.5772/intechopen.81979
Functional 
class
BER protein PTM and 
identified site
BER 
activity
Protein 
stability
Reference
End 
processors
Apurinic/
apyrimidinic 
endonuclease 1 
(APE1)
Acetylation; K6, K7, 
K27, K31, K32, K35
+ + [135, 136, 
236–238]
Phosphorylation; 
T233
− [239, 240]
Ubiquitination; K6, 
K7, K24, K25, K27, 
K31, K32, K35
− [137, 138, 
241]
Polynucleotide 
kinase 
phosphatase 
(PNKP)
Phosphorylation; 
S114, S126
+ + [139–141]
Ubiquitination; 
K414, K417, K484
− [139]
Flap 
endonuclease-1 
(FEN-1)
Acetylation; K354, 
K355, K377, K380
− [242]
Phosphorylation; 
S187
− − [144, 145]
Methylation; R192 + + [146]
SUMOylation; K168 − [143]
DNA 
polymerases
DNA polymerase 
β (Pol β)
Acetylation; K72 − [147]
Methylation; R137, 
R83, R152
+ [148, 149]
Ubiquitination; 
K41, K61, K81
− [150, 151]
DNA polymerases 
δ (Pol δ)
Phosphorylation; 
S458 of p68 subunit
− [243]
DNA ligases DNA ligase IIIα 
(Lig IIIα)
Phosphorylation; 
S123
[244]
Ubiquitination − [150, 245]
Accessory 
proteins
X-Ray 
repair cross-
complementing 1 
(XRCC1)
Phosphorylation; 
S518, T519, T523, 
C-terminal linker, 
T284, S371
+ + [246–252]
SUMOylation [152, 253]
Ubiquitination; 
BRCA1 C terminus 
(BRCT II) motif on 
the C-terminal end
− [150, 245, 
252]
Poly(ADP-ribose) 
polymerase 1 
(PARP-1)
Acetylation; K498, 
K505, K508, K521, 
K524
[254]
Phosphorylation; 
S372, T373
+ [255]
SUMOylation; 
K203, K482, and 
K486
[132, 133]
Ubiquitination − [132, 245, 
256]
Table 2. 
PTMs of BER proteins.
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threonine residues [90, 91]. Subsequently, various kinases that phosphorylate 
serine/threonine and later tyrosine residues were characterized for their ability to 
modulate protein functions [91–93]. As with acetylation, phosphorylation induces 
conformational changes in the protein that stimulates its enzymatic activity and 
modulates protein-protein interactions [92, 94, 95]. Although the initial studies 
in protein phosphorylation were focused on cellular communications and signal 
transduction pathways, eventually the critical role of protein kinases and the 
relevance of phosphorylation/dephosphorylation events in DNA damage response 
(DDR) are extensively acknowledged, and mass spectrometry-based global screen-
ing approaches enabled identification of diverse phosphorylation targets [96, 97].
6.3 Ubiquitination and SUMOylation
Proteins are also posttranslationally modified via isopeptide bond formation 
with small proteins, which leads to nonlinear polypeptides [98, 99]. Ubiquitin is 
the first-discovered and well-characterized member of this growing family of small 
peptide modifiers, which covalently modify diverse proteins involved in chromatin 
organization, gene expression, signal transduction, DDR, DNA repair, and protein 
degradation [100–102]. Ubiquitin signals are generated by an enzymatic cascade 
involving E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and 
E3 ubiquitin ligases. Ubiquitination is a highly dynamic process with deubiquitin-
ases (DUBs) involved in this signaling, and growing evidence indicates the involve-
ment of ubiquitination/deubiquitination in BER, as shown in Table 2.
Small ubiquitin-related modifier (SUMO), containing 100 amino acid (aa) 
residues protein, is ubiquitin-like polypeptide, which is conjugated to substrates in 
a manner similar to ubiquitination [102, 103]. The SUMO paralogs are synthesized 
as precursor proteins that are cleaved by a family of SUMO isopeptidases [104]. 
Mature SUMO is subsequently activated by a heterodimeric E1-activating enzyme 
Aos1/Uba2 (SAE1/SAE2) forming a thioester bond between its catalytic cysteine 
and the C-terminal carboxyl group of mature SUMO. Then SUMO is transferred 
to the catalytic cysteine of the E2-conjugating enzyme Ubc9. In contrast to the 
ubiquitin system where dozens of E2 enzymes have been identified, Ubc9 is the 
only known SUMO E2 conjugating enzyme. Finally, an isopeptide bond is formed 
between SUMO and the substrate by E3 ligases. A consensus SUMO acceptor site 
has been identified consisting of the sequence ΨKXE, where Ψ is a large hydro-
phobic amino acid and K is the site of SUMO conjugation [105]. There are at least 
four SUMO paralogs in humans, SUMO1, SUMO2, SUMO3, and SUMO4, which 
have more than 1000 protein targets. SUMOylation is highly dynamic and can 
be reversed by the action of deSUMOylating enzymes (SENPs). SUMOylation 
regulates protein-protein interactions involving SUMO-interacting motifs (SIMs), 
and it targets a group of proteins in the same pathway to facilitate association of 
multiprotein complexes for transcription, nuclear transport, chromatin assembly 
and modification, chromosome segregation, DNA damage repair, replication, and 
cell signaling [106, 107].
6.4 PARylation
Poly ADP-ribosylation (PARylation), a crucial PTM that appears rapidly at 
DNA damage sites, is catalyzed by poly(ADP-ribose) polymerases (PARPs). The 
human PARP family contains 17 members among which only PARP1, 2, and 3 are 
involved in DDR [108–111]. PARPs covalently attach the ADP-ribose unit via an 
ester bond to the carboxyl group of glutamate or aspartate and sometimes also 
attach to cysteine or lysine of the target proteins [112–114]. PARPs successively 
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transfer ADP-ribose units from NAD+ to produce PAR chains containing up to 200 
ADP-ribose units; however, in many cases, only single mono ADP-ribose moiety 
is transferred to the target proteins. Strand breaks in DNA activate PARP1, the 
founding and predominant member of the PARP family; the primary substrate 
of PARP1 is itself. Many proteins in the DDR pathways as well as the damage 
processing enzymes interact with PARP1 and/or are PARylated [112, 115]. In cells, 
PARylation/dePARylation is tightly and dynamically regulated; the PAR polymers 
are degraded by PAR glycohydrolase (PARG), possessing both exoglycosidic and 
endoglycosidic activities, and release free ADP-ribose moieties [116–118]. ADP-
ribosyl-acceptor hydrolase (ARH) also exhibits PAR-degrading activity, although it 
has only exoglycosidase activity [119, 120]. Retention of PAR chains in cells triggers 
apoptotic cell death [121]. Although PARP1 interacts with the SSBR sensor XRCC1, 
as well as with other BER/SSBR proteins, and enables early recruitment of XRCC1 
to the DNA lesions [122–126], there is no convincing evidence for PARylation of 
BER/SSBR proteins.
6.5 Cross-talks between different PTMs, their regulation, and effect on BER
Proteins employ diverse PTMs sequentially or concurrently to expand their rep-
ertoire of functions, thereby impacting global cellular signaling. The best example 
is the disordered N-terminal tail of histone H3, which has multiple sites for acetyla-
tion, methylation, phosphorylation, ubiquitination, and SUMOylation [69, 70].  
These PTMS could act synergistically or via reciprocal exclusion to modulate 
chromatin organization, thus affecting the transcriptome. The same Lys residues 
(K9, K27) in H3 are targets for both acetylation (marker of active chromatin) and 
methylation; however, monomethylation of these residues are markers of active 
chromatin, while di- and trimethylation are associated with repression. Recent 
evidence on BER enzymes, summarized below, suggests that specific modification 
at one site can dramatically influence another modification at a different site, which 
may critically impact BER activity.
Cyclin-dependent kinase (CDK)-mediated phosphorylation of UNG2 (nuclear 
UDG) in S phase signals its ubiquitination-dependent degradation, and CDK-
inhibitor roscovitine prevents such degradation [127, 128]. This suggests that 
phosphorylation-induced conformational change in UNG2 is a prerequisite for 
ubiquitination.
In the case of TDG, acetylation inhibits its repair activity by two distinct 
mechanisms. TDG acetylation at K94, K95, and K98 by p300/CBP suppresses BER 
by preventing APE1 recruitment to the damage site [129]. Protein kinase C (PKC)-
mediated phosphorylation at S93, S96, and S99, close to the acetylation sites, may 
promote repair by sterically blocking repair-inhibitory acetylation of adjacent lysine 
residues [130]. On the other hand, SUMOylation at K341 inhibits TDG’s interaction 
with CBP, preventing its acetylation and thereby promoting BER [131].
PARP1, SUMOylated at K203 and K486, is a target for ubiquitination and degrada-
tion, which is believed to be the mechanism for its turnover [132]. In contrast, PARP1’s 
SUMOylation at K482 does not degrade the protein, rather stimulates PARylation of 
chromatin-associated proteins [133]. On the other hand, acetylation of PARP1, which 
stimulates its transactivation function, is inhibited by K486 SUMOylation. Thus, 
K486 SUMOylation restrains PARP1’s transactivation function [134].
While acetylation of APE1 enhances its stability in chromatin and enzymatic 
activity [135, 136], CDK5-mediated phosphorylation enhances its ubiquitination 
and degradation [137, 138]. Thus, it is possible that phosphorylation and acetylation 
are mutually exclusive, acetylation stabilizing the protein, and phosphorylation 
guiding to its degradation.
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In the case of PNKP, ATM-dependent phosphorylation was shown to prevent 
ubiquitination and hence its degradation. Thus, in response to oxidative stress,  
ATM phosphorylates and stabilizes PNKP in order to activate a coordinated DDR 
pathway [139–141]. Furthermore, PNKP interacts with the deubiquitination enzyme 
ataxin-3 (ATXN3), which enhances its stability and phosphatase activity [142].
Phosphorylation of FEN-1 by CDK1 at S187 was shown to promote SUMOylation 
at K168, which enhanced its polyubiquitination-dependent degradation [143]. 
Phosphorylation inhibits FEN-1’s flap endonuclease activity [144, 145], which 
cross-talks with methylation, a lesser studied PTM of BER proteins. Methylation 
by arginine methyltransferase 5 at R192 prevents this phosphorylation and thus is 
proposed to be essential for the repair activities of FEN-1 [146]. Thus, in response to 
oxidative stress in cycling cells, methylation of FEN-1 could be a critical requirement 
for LP-BER.
Acetylation of Pol β at K72 inhibits its dRP lyase activity [147], and this could 
account for acetylation-induced inhibition of enzymatic activity and switch from 
SN-BER to LP-BER. Methylation of Pol β at R137 has no effect on dRP lyase or DNA 
polymerase activities but inhibits its interaction with PCNA [148] and could thus be 
predicted to inhibit LP-BER. In contrast, R83 and R152 methylation enhanced Pol β’s 
DNA binding and increased processivity [149]. Cellular Pol β level appears to be 
maintained by two ubiquitin E3 ligases, Mule and CHIP. DNA Pol β is monoubiq-
uitinated by Mule, which in turn is recognized and polyubiquitinated by CHIP in 
undamaged cells. In response to oxidative stress, it is deubiquitinated, thus ensuring 
its stability and oxidized base damage repair [150, 151].
A recent study shows how PARylation stimulates SUMOylation [152]. In response 
to DNA strand breaks induced by alkylating agent methylmethanesulfonate (MMS), 
PARP1 is activated and synthesizes PAR chains; this promotes recruitment of SUMO 
E3 TOPORS to XRCC1, which facilitates XRCC1 SUMOylation. XRCC1 SUMOylation 
recruits Pol β at the damaged sites and thus ensures completion of BER.
7.  Does chromatin organization affect BER? Understanding BER at the 
chromatin context
BER, as studied in vitro with naked DNA substrates, involves sequential enzymatic 
steps in which each enzyme utilizes the product of the previous step as the substrate. 
This observation inspired the prevailing dogma that the sequential steps in BER 
involves the hand-off process where the product of one step is handed over to the 
enzyme in the next step [153, 154]. Later steps generate intermediate product lesions 
that are more toxic than the original lesions. The BER intermediates such as AP sites 
and SSBs, which are highly mutagenic, interfere with replication and transcription, 
and hence the entire BER steps must be coordinated once the repair is initiated  
[155–158]. Cumulating evidence suggests that the BER proteins act in concert beyond 
simply recognizing and acting upon the product of the previous step, by being present 
at the site of the original lesion [43, 52, 61, 62, 64, 65, 125, 159, 160]. This is the basis 
for the emerging paradigm of “preformed BER complexes,” named, “BERosomes” in 
mammalian cells. Being an integral part of complexes, it may be easier for the BER 
intermediates to be handed over to the next enzyme, which likely undergoes allosteric 
changes after binding to its substrate. Recent studies in our and collaborators’ labs 
suggest that these “BERosomes” are constitutively chromatin-bound to ensure prompt 
repair in the event of any threat [62, 135, 161]. Simultaneously, recent interests in the 
BER field have evolved toward deciphering the role of different chromatin factors and 
the underlying chromatin remodeling in oxidized base repair.
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Several in vitro studies showed reduced BER activity with reconstituted core 
nucleosome particles, where every step during repair of diverse lesions was found 
to be inhibited by histones [162–170]. Overall BER efficiency is strongly inhibited 
by the presence of nucleosomes, which interfere with the interaction between the 
repair proteins and their substrate lesions, thereby compromising physical interaction 
and catalysis. Because oxidized bases perturb the DNA structure only mildly [170], 
whether chromatin remodeling occurs during BER was questionable. But, as BER effi-
ciently occurs in cells, the results from these in vitro experiments imply that chromatin 
rearrangement occurs at oxidized DNA damage sites in cells, as was shown in the case 
of repair of DSBs, UV ray-mediated damages, and mismatched base pairs [171–173].
An inverse correlation exists in cells between BER and chromatin compaction. 
ROS induces assembly of BER complexes preferentially on open chromatin regions 
[174], as we have also observed that the BER complexes are constitutively present on 
actively transcribing sequences [175]. Interestingly, BER is involved during active 
CpG demethylation in promoters, mediated by TET dioxygenase(s) during tran-
scriptional activation [176–180]. The TET proteins oxidize 5mC to 5hmC, 5fC, and 
5caC; 5fC and 5caC are the TDG substrates. Thus, this coordination between CpG 
DNA demethylation, an epigenetic process essential for chromatin decondensation 
during transcriptional activation, and base damage repair supports our notion that 
“open-chromatin prefers BER activity across the genomic landscape” and highlights 
a regulatory link between epigenetics, chromatin remodeling, and BER.
Various ATP-dependent chromatin remodeling (ACR) complexes, which play 
significant roles in protein/DNA and protein/protein interactions in chromatin 
and regulate transcription, DNA repair processes such as DSB repair (DSBR), 
nucleotide excision repair (NER), and cross-link repair, also affect BER. ACR 
complexes utilize the energy of ATP hydrolysis to restructure nucleosomes on 
chromatin [181–183], thereby affecting gene expression profile and DNA repair. 
Four structurally related, but functionally distinct, ACR complex families 
were identified: SWI/SNF (switching defective/sucrose nonfermenting; most 
extensively studied), ISWI (imitation switch), CHD (chromodomain, helicase, 
DNA binding), and INO80 (inositol requiring 80). In vitro BER studies with 
reconstituted nucleosomes showed enhanced repair activity in the presence of 
purified SWI/SNF or ISW1/ISW2 complexes [184–186]. There are some indirect 
evidences of ACR during BER in yeast and mammalian cells. Depletion of STH1 
(ATPase subunit of RSC, a member of SWI/SNF family) causes genome-wide BER 
inhibition and thus emphasizes a link between chromatin organization and BER 
[187]. In a recent study, depletion of ALC1/CHD1L, another member of SWI/SNF, 
compromises chromatin relaxation, associated with BER inhibition and increased 
sensitivity to MMS and H2O2 in chicken cells [188]. On the contrary, INO80 
deficiency in MMS-sensitive yeast cells has no effect on genome-wide BER [189]. 
K56 acetylation in histone H3 is increased in chromatin of both yeast and mam-
malian cells following MMS treatment, which generates alkylated base substrates 
for BER, [190, 191]. H3K56Ac was also found to be enriched at DSBR sites and 
responsible for SWI/SNF complex recruitment during transcription [192]. Thus, 
it would be interesting to examine if any specific PTM(s) would target ACR after 
oxidized base damage and illuminate the phenomenon of ACR during BER. In any 
event, additional studies are required to test if ACR plays a role in enabling BER 
in condensed chromatin. It would be also of interest to explore if the BER proteins 
possess inherent chromatin remodeling activities, similar to the NER proteins, 
which have SWI/SNF domains [193–195]. Though no known BER proteins have 
SWI/SNF domains, the XRCC1-Lig IIIα complex could disrupt nucleosomes in 
vitro and enable BER completion [166].
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Poly-ADP-ribosylation of histones by PARP1 after genome damage adds nega-
tive charge on histones and disrupts histone-DNA interactions, thereby promot-
ing chromatin decondensation and enhancing interaction between the proteins 
involved in DNA transactions and DNA [111, 196–198]. This could increase DNA 
accessibility to the BER proteins. Although PARP1’s role in regulating transcrip-
tion is well established, this would link chromatin remodeling to BER.
Nucleosomes pose obstruction to all DNA transactions and are likely disassembled 
to allow DNA replication, repair, and transcription, followed by their reassem-
bly, which utilizes both parental histones and newly synthesized histones. Such 
replication-coupled nucleosome assembly in the S phase or replication-independent, 
transcription-coupled assembly throughout the cell cycle involves histone chaperones 
functioning at multiple steps of nucleosome formation [172, 199, 200]. Replication-
coupled nucleosome assembly is aided by the chromatin assembly factor (CAF-1) 
and Rtt106 with the help of antisilencing function 1A (ASF1A) protein. Histone cell 
cycle regulator (HIRA) protein, along with Daxx, mediates replication-independent 
nucleosome assembly. While exploring chromatin-bound BER complexes, we 
serendipitously discovered CHAF1A (the largest subunit of CAF-1, along with 
other subunits CHAF1B and RBBP4), ASF1A, and various H3/H4 variants in the 
immunoprecipitation complex of NEIL1 or acetylated NEIL1 (201; unpublished). 
This underscores the importance of the diverse chromatin components in preformed 
“BERosomes,” which could regulate oxidize base repair in chromatin. We showed 
that ROS-induced oxidized base lesions caused transient dissociation of CHAF1A, 
ASF1A, and histones from the BER complexes and were restored back after repair 
completion. The repair activities of NEIL1 and OGG1, as well as complete cellular 
BER, were found to be inhibited by CAF-1, as well as the CHAF1A monomer [201]. 
So, we propose a hypothesis of temporal regulation of BER by the histone chaperones, 
whose dissociation from BER complexes is essential to initiate BER [201]. This has 
been illustrated in Figure 2.
Recently, we discovered acetylation of NEIL1 at the disordered C-terminal 
K296-K298 by p300, which enhances its activity, and found that acetylated NEIL1 
(AcNEIL1) could be detected only in the chromatin fraction and not in the soluble 
nuclear fraction [161]. Although the nonacetylable NEIL1 3KRmutant (Lys296–298 
substituted with Arg) translocates to the nucleus and binds to chromatin, presumably 
due to retention of positive charges as in the WT enzyme, it forms less stable BER com-
plexes with the histones, histone chaperones, and downstream BER proteins. Thus, as 
proposed earlier [65], the positive charge cluster in the disordered C-terminal region 
is required for NEIL1’s nonspecific DNA binding, after which acetylation occurs on 
the chromatin. Hydrophobic interaction of NEIL1 after acetylation-mediated charge 
neutralization probably stabilizes NEIL1’s complexes with nucleosome components 
and downstream BER proteins. Consequently, cells with acetylable NEIL1 exhibit 
enhanced BER efficiency and are less sensitive to oxidative stress. It is thus likely that 
unmodified NEIL1 binds to chromatin nonspecifically, and acetylation specifically at 
the promoter regions of actively transcribing genes by enhanced p300 activity actually 
stabilizes NEIL1’s (and possibly other DG’s) BERosomes on these preferred chromatin 
regions (Figure 3), which warrants further investigation.
In a separate study, while investigating how APE1 repairs AP sites in cells, our 
collaborator’s lab found that acetylated APE1 (AcAPE1), like AcNEIL1, is exclu-
sively and stably chromatin-bound throughout the cell cycle [135]. APE1 undergoes 
acetylation after binding to AP sites in chromatin, which enhances its enzymatic 
activity. In the absence of APE1 acetylation, cells accumulated AP sites and exhib-
ited higher sensitivity to DNA damaging agents. We predict that other BER proteins 
OGG1 and MPG, whose repair activity is enhanced by acetylation, are similarly 
stabilized in chromatin-bound state.
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8. Future perspectives
The genome-wide impact of various PTMs in the cross-talks among BER pro-
teins, which dictates the overall repair efficiency, thus preserving genomic integrity 
against genotoxic insults from both endogenous and external oxidative stress, 
has not been investigated. In this NextGen era, holistic, whole-genome scanning 
approaches, although a daunting challenge, make it likely to map individual PTMs 
of BER proteins, the kinetics of their formation and removal, and their correlation 
with both intrinsic and ROS-induced BER efficiency across the genomic landscape. 
Because histone PTMs have been well established in chromatin remodeling, it is also 
important to explore how specific histone PTMs interfere with the BER PTMs.
The Access-Repair-Restore model [182, 202] provides an accepted view of DNA 
repair in chromatin, where chromatin remodeling is essential for the DNA repair 
machineries to get access to the damaged DNA. For BER, it is still not clear how chro-
matin remodeling and the associated histone PTMs initiate BER. The BER complexes 
constitutively bind to “open” chromatin regions, and chromatin remodeling could assist 
specific enzyme-substrate binding and enzyme catalysis needed to initiate and propa-
gate BER. Moreover, although chromatin remodeling has been found to enable BER, the 
enhanced repair activity may be simply due to ROS-induced stimulation of BER genes’ 
expression or their specific PTM (acetylation), as has been shown by us [203–205], 
along with enhanced substrate binding in “open” chromatin. This may underesti-
mate the contribution of ACR complexes at oxidized base lesion sites to enhance 
BER. Alternatively, in cells, chromatin remodeling-stimulated BER could be linked 
to replication and transcription, similar to transcription-coupled NER, which always 
occurs on “open” chromatin [206]. Indeed, repair of oxidized bases preferentially 
occurs in the transcribed strand [175], which could be assisted by Cockayne syndrome 
protein B (CSB), a NER factor, in transcription-coupled but NER-independent fashion 
[207]. Because BER/SSBR proteins such as PARP1 and APE1 are emerging as potential 
Figure 2. 
A schematic showing chromatin-bound BER complexes with histones and histone chaperones. ROS-induced 
damage causes transient dissociation of histones and histone chaperones to initiate BER, which are restored 
back after repair completion.
Figure 3. 
An illustrative view of “open” chromatin regions, containing bound “BERosomes” with histones, histone 
chaperones, PARPs, TETs, etc., for preferential repair of these transcriptionally active regions.
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therapeutic targets [208–212], understanding if and how chromatin remodeling 
impacts BER activity is crucial to manipulating BER for effective modulation of repair 
activity in cancer cells. This would provide better efficacy and specificity in cancer 
therapy.
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